CAJ | 학술논문

目的:探讨血塞通在老年人急性脑梗死治疗中的临床应用价值.方法:将本院2011年1月~2011年12月在本院诊治的82例急性脑梗死患者随机分成2组:①实验组41例;②对照组41例.对照组单纯给予阿托伐他汀治疗;实验组给予阿托伐他汀+血塞通治疗.观察比较两组的临床疗效、血凝系统和血液流变学的变化情况.结果:实验组的总有效率为82.93%,对照组的总有效率为56.09%,实验组的临床疗效明显优于对照组(P<0.05);实验组患者治疗后的Fbg、TT、PT、INR、APTT指标水平均显著性优于对照组(P<0.05);实验组患者治疗后的高切ηb、低切ηb、FIB、ηp、HCT指标水平均显著性优于对照组(P<0.05).结论:临床应用血塞通治疗急性脑梗死的效果显著.
목적:탐토혈새통재노년인급성뇌경사치료중적림상응용개치.방법:장본원2011년1월~2011년12월재본원진치적82례급성뇌경사환자수궤분성2조:①실험조41례;②대조조41례.대조조단순급여아탁벌타정치료;실험조급여아탁벌타정+혈새통치료.관찰비교량조적림상료효、혈응계통화혈액류변학적변화정황.결과:실험조적총유효솔위82.93%,대조조적총유효솔위56.09%,실험조적림상료효명현우우대조조(P<0.05);실험조환자치료후적Fbg、TT、PT、INR、APTT지표수평균현저성우우대조조(P<0.05);실험조환자치료후적고절ηb、저절ηb、FIB、ηp、HCT지표수평균현저성우우대조조(P<0.05).결론:림상응용혈새통치료급성뇌경사적효과현저.
Objective:To investigate the clinical value about Xuesaitong for the treatment of elderly patients with acute cerebral infarction.Methods:The 82 cases of elderly acute cerebral infarction patients admitted to hospital from January 2010 to December 2011 were randomly divided into two groups, control group (n=41) and treatment group (n=41).The control group was treated with atorvastatin only, but the treatment group was treated with atorvastatin and Xuesaitong.The clinical effects, the changes of coagulation system and hemorheological in 2 groups was observed and compared.Results:The total effective rate was 82.93% in the treatment group, but the control group was 56.09%,so the clinical effects in the treatment group was significantly better than the control group (P<0.05); the index value of Fbg,TT,PT,INR,APTT in the treatment group after treated were significantly better than the control group (P<0.05); the index value of ηb, FIB, ηp,HCT in the treatment group after treated were significantly better than the control group (P<0.05).Conclusion:There is a significant clinical effect of Xuesaitong for the treatment of elderly patients with acute cerebral infarction.